Skip to main content

Table 3 Dyslipidemia prevalence in the sample (cases)

From: Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of mexican population: a preliminary report

Variable

TAG* (mg/dL)

TC* (mg/dL)

HDL-C* (mg/dL)

LDL-C* (mg/dL)

 

<200

>200

<(200/240)

>(200/240)

<35

>35

<130

>130

Initial (n = 36)

21

15

26/33

10/3

10

26

27

9

Final (n = 36)

28

8

31/36

5/0

8

28

33

3

  1. * p < 0.05 initial vs. final, chi-squared test
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X